Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Torch Bio
Michigan, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Torch Bio provides preclinical efficacy and safety profiling using patient-derived iPSC liver organoids and AI/ML models for drug-induced liver injury and liver disease; it operates as a discovery and safety CRO and does not publicly disclose proprietary therapeutic assets or clinical-stage programs.[1][5]
- Therapeutic areas
- CardiovascularGastroenterologyMetabolic Disorders
- Modalities
- Small moleculeBiologicmRNA-based drugsGene therapy
- Industry
- Non-Drug Biotech
02
Partnerships
Inductive Bio (AI drug toxicity modeling collaboration under ARPA-H CATALYST DATAMAP project)Amgen (through the same ARPA-H consortium)Cincinnati Children's Hospital Medical CenterBaylor College of Medicine
Beyond the preview
Go deeper on Torch Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Torch Bio.